Sveriges mest populära poddar

GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)

8 min•16 juni 2016

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Intelligence

Anthropic in Talks to Buy Startup Decart for $6 Billion

13 aug.•25 min

CoreWeave Shares Soar After Booming AI Demand Boosts Outlook

12 aug.•26 min

Apollo Inks $2.6 Billion Financing Deal With NY Yankees

11 aug.•21 min

Intel to Sell $15 Billion in Stock After AI Boosts Demand

10 aug.•22 min

Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase

8 aug.•43 min

Under Armour Cuts Sales View on Softer Demand Around the World

7 aug.•22 min

Warner Bros. Sales Fall on Loss of NBA, Weak Film Slate

6 aug.•28 min

SpaceX’s $101 Billion Unlock Heaps Pressure on Battered Shares

5 aug.•27 min

Earnings Special: SpaceX’s AI Splurge Puts a Damper on Debut Earnings After IPO

5 aug.•20 min

Palantir Jumps After ‘Otherworldly Demand Lifts Outlook

4 aug.•22 min

Bloomberg Intelligence med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.